Thalidomide Survivors Compensation Act of 2025
- Bill Number
- H.R. 5865
- Origin Chamber
- House
- Congress
- 119th Congress, Session 1
- Policy Area
- Health
- Status
- Introduced
- Latest Action
- 2025-10-28: Referred to the Committee on the Judiciary, and in addition to the Committees on Ways and Means, Energy and Commerce, Natural Resources, Agriculture, Education and Workforce, Financial Services, Transportation and Infrastructure, and Veterans' Affairs, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- Last Updated
- 2026-07-09T16:38:31Z
AI-Generated Summary
Purpose of the Legislation
The Thalidomide Survivors Compensation Act of 2025 aims to provide financial compensation and support to U.S. survivors of thalidomide exposure, a drug linked to severe birth defects in the 1950s and 1960s. It seeks to help these individuals live with greater independence and dignity by addressing decades of unreimbursed medical costs, accessibility barriers, and lack of formal recognition. The act recognizes that while thalidomide was not officially approved in the U.S., it was distributed informally, affecting an estimated 100 living survivors.
Key Provisions
- Establishment of the Program: The Secretary of Health and Human Services (HHS) must create the Thalidomide Survivors Compensation Program within one year of enactment. Eligible individuals can petition for compensation if they can prove exposure to thalidomide and resulting injuries (e.g., limb deformities or organ issues) through medical documentation.
- Compensation Amount and Process: Approved petitioners receive a one-time payment of $150,000. An expert panel of legal, medical, and thalidomide experts, plus survivors, reviews petitions. Only one petition per person is allowed, with a submission deadline of May 31, 2034.
- Eligibility Restrictions: Limited to U.S. citizens or permanent residents at the time of exposure and petition submission.
- Protections for Recipients: Payments are excluded from federal income taxes and do not count as income or assets for eligibility in means-tested welfare programs (e.g., Medicaid, SNAP, or housing assistance). The act includes a detailed list of such programs, covering areas like cash aid, medical care, food, housing, energy, education, training, and more.
- Ongoing Support and Oversight: HHS must conduct annual reviews of the program starting one year after establishment, reporting to Congress on effectiveness, fund usage, recipient numbers, and survivor needs. Based on reviews, additional compensation may be provided for medical or other ongoing needs, subject to available funds.
- Funding: Authorizes appropriations for fiscal years 2028 through 2034 as needed by HHS.
Significant Changes to Existing Law
- New Compensation Framework: This introduces a dedicated federal program for thalidomide survivors, which did not previously exist in U.S. law. It amends the Internal Revenue Code (adding section 139M) to make compensation tax-free, effective for payments after enactment.
- Welfare and Tax Implications: Explicitly defines "means-tested welfare programs" (low-income assistance programs) and ensures compensation does not affect eligibility, overriding any prior rules that might count such payments. This protects survivors from losing benefits in programs like Social Security, Medicare, or food assistance.
- No direct amendments to other laws, but it sets a time-limited structure (program ends by 2034) unlike ongoing entitlements.
Potential Impacts
- On Citizens: Primarily benefits an estimated 100 U.S. thalidomide survivors by providing financial relief for medical, adaptive living, and daily needs, potentially improving quality of life without risking welfare benefits. It may encourage formal diagnosis and documentation of thalidomide-related conditions.
- On Government Agencies: HHS gains responsibility for program administration, petition reviews, and annual reporting, requiring new resources and an expert panel. The IRS must implement tax exclusions. Congress will receive oversight reports, possibly leading to future funding adjustments. Total costs are not specified but tied to appropriations for about 100 recipients.
- On International Relations: Minimal direct impact, though it aligns the U.S. with 46 other countries offering similar support (e.g., pensions or adaptive aid), potentially enhancing the U.S. image on historical health injustices without affecting foreign policy.
Main Stakeholders Affected
- Thalidomide Survivors: Primary beneficiaries, including U.S. citizens and permanent residents exposed in utero during the 1950s–1960s.
- Federal Agencies: HHS (administration and reviews), IRS (tax handling), and welfare program administrators (e.g., Social Security Administration, USDA for food programs) to ensure non-interference with benefits.
- Congress and Taxpayers: Involved in funding authorizations and oversight; indirect impact through appropriated funds.
- Medical and Legal Experts: Panel members reviewing petitions.
- Advocacy Groups: Thalidomide survivor organizations may influence annual recommendations for expansions.
Notable Legal, Constitutional, or Political Implications
- Legal: Establishes a clear, evidence-based process for compensation claims, relying on medical proof rather than litigation, which could reduce court burdens. The tax exclusion and welfare protections prevent unintended legal challenges over benefit reductions. The program's time limit (to 2034) balances equity with fiscal control.
- Constitutional: Aligns with Congress's spending power under Article I, providing targeted relief without broad entitlements. No apparent free speech, due process, or equal protection issues, as eligibility is narrowly defined by citizenship and exposure.
- Political: Addresses a long-overlooked historical wrong (informal U.S. drug distribution), potentially setting precedent for compensating victims of other past medical harms (e.g., vaccines or trials). It promotes bipartisanship on health equity but may spark debates on federal spending priorities amid limited survivor numbers. Referred to multiple committees (e.g., Judiciary, Ways and Means), indicating broad jurisdictional review.
This summary was generated by AI and may contain inaccuracies. Refer to the official source document for the authoritative text.
Sponsor
Rep. Van Drew, Jefferson [R-NJ-2]
Recent Actions
- 2025-10-28: Referred to the Committee on the Judiciary, and in addition to the Committees on Ways and Means, Energy and Commerce, Natural Resources, Agriculture, Education and Workforce, Financial Services, Transportation and Infrastructure, and Veterans' Affairs, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- 2025-10-28: Referred to the Committee on the Judiciary, and in addition to the Committees on Ways and Means, Energy and Commerce, Natural Resources, Agriculture, Education and Workforce, Financial Services, Transportation and Infrastructure, and Veterans' Affairs, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- 2025-10-28: Referred to the Committee on the Judiciary, and in addition to the Committees on Ways and Means, Energy and Commerce, Natural Resources, Agriculture, Education and Workforce, Financial Services, Transportation and Infrastructure, and Veterans' Affairs, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- 2025-10-28: Referred to the Committee on the Judiciary, and in addition to the Committees on Ways and Means, Energy and Commerce, Natural Resources, Agriculture, Education and Workforce, Financial Services, Transportation and Infrastructure, and Veterans' Affairs, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- 2025-10-28: Referred to the Committee on the Judiciary, and in addition to the Committees on Ways and Means, Energy and Commerce, Natural Resources, Agriculture, Education and Workforce, Financial Services, Transportation and Infrastructure, and Veterans' Affairs, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- 2025-10-28: Referred to the Committee on the Judiciary, and in addition to the Committees on Ways and Means, Energy and Commerce, Natural Resources, Agriculture, Education and Workforce, Financial Services, Transportation and Infrastructure, and Veterans' Affairs, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- 2025-10-28: Referred to the Committee on the Judiciary, and in addition to the Committees on Ways and Means, Energy and Commerce, Natural Resources, Agriculture, Education and Workforce, Financial Services, Transportation and Infrastructure, and Veterans' Affairs, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- 2025-10-28: Referred to the Committee on the Judiciary, and in addition to the Committees on Ways and Means, Energy and Commerce, Natural Resources, Agriculture, Education and Workforce, Financial Services, Transportation and Infrastructure, and Veterans' Affairs, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- 2025-10-28: Referred to the Committee on the Judiciary, and in addition to the Committees on Ways and Means, Energy and Commerce, Natural Resources, Agriculture, Education and Workforce, Financial Services, Transportation and Infrastructure, and Veterans' Affairs, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- 2025-10-28: Introduced in House
- 2025-10-28: Introduced in House
Bill Versions
- Thalidomide Survivors Compensation Act of 2025 — issued 2025-10-28 — PDF (20 pages)